‘It appears Centre wants people to die’: Delhi HC slams new protocol on Remdesivir use

‘It appears Centre wants people to die’: Delhi HC slams new protocol on Remdesivir use

"Now people who do not have oxygen will not get Remdesivir either."

The Delhi High Court on Wednesday fired a fresh salvo at the Centre, criticising its new protocol on the use of Remdesivir. As per the new protocol, the drug was to be given only to those on oxygen support.

"This is wrong. This is a complete non-application of mind. Now people who do not have oxygen will not get Remdesivir either. It appears you want people to die," Justice Prathiba M. Singh said to the central government.

The court was hearing a PIL in which the petitioner, a COVID-19 patient, alleged that he was given only three out of the six doses of Remdesivir required.

After the court's intervention, he got the remaining vials on Tuesday night.

“This is complete mismanagement," the court said, adding that it appeared the Centre was changing the protocol to reduce the shortage of the drug.

‘It appears Centre wants people to die’: Delhi HC slams new protocol on Remdesivir use
Dexamethasone, remdesivir, plasma, doxycycline: Which works for Covid and which doesn’t

On Tuesday, the high court had said that millions of vials of Remdesivir, used in treatment of COVID-19, may have been exported by India, but its own citizenry was "suffering due to acute shortage of the drug".

The court observed that several companies in India were manufacturing the medicine and millions of vials of the drug must have been exported, "but we do not have enough to cater to our own patients".

The court had also asked the Centre on what basis it was deciding how much of the drug was to be allocated to the Delhi government and whether anyone can directly approach the manufactures or suppliers for buying the medicines.

No stories found.
Indians In Gulf
www.indiansingulf.in